Financials
- Financial year
- 2025
- Total assets
- €495,446
- Profit
- €94,284
- Solvency
- 37.4%
Total assets▲ 125%
Net result
20192025
W.P. MED
ActiveSummary
W.P. MED has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €185,377 and a net result of €94,284. Equity is growing by about 56% per year across the filed financial years. Its solvency ranks better than 48% of 13,626 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Activity
Wholesale of pharmaceutical and medical goods
NACE 46460Agents specialised in the wholesale of other particular products NACE 46180
1 site
Size
€495,446total assets 2025
- Equity
- €185,377
- Profit
- €94,284
Turnover not published (micro format)
Structure
- PATTERSON WilliamDirector
Accounts 32 days early1 of 2 deeds read
Why 70raises riskFigures for financial year 2025 (filed 01-10-2025)Liquidity: current ratio 1.58, cash €6,400, halvedSector: Wholesale trade (NACE 46)lowers riskSize: total assets €495,446Show the evidence
Checked score
Score 2025
70
/ 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 51% of its sector peers (NACE 46, micro)
Financial strength · tick = 2023
Average
Solvency
62-9
equity 37.4% of total assets
Liquidity
20-22
short-term debt 60.9% · cash 1.3%
Profitability
93-7
return on assets 19.0%
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 1.1%
12-2024: 1.2%▲ +0.1 percentage points vs 11-2024
01-2025: 2.5%▲ +1.3 percentage points vs 12-2024
02-2025: 2.6%▲ +0.1 percentage points vs 01-2025
03-2025: 3.2%▲ +0.6 percentage points vs 02-2025
04-2025: 4.3%▲ +1.1 percentage points vs 03-2025
05-2025: 4.1%▼ -0.2 percentage points vs 04-2025
06-2025: 4.4%▲ +0.3 percentage points vs 05-2025highest value
07-2025: 4.0%▼ -0.4 percentage points vs 06-2025
08-2025: 4.0%● unchanged vs 07-2025
09-2025: 4.0%● unchanged vs 08-2025
10-2025: 4.0%● unchanged vs 09-2025
11-2025: 0.3%▼ -3.7 percentage points vs 10-2025lowest value
12-2025: 0.3%● unchanged vs 11-2025lowest value
01-2026: 0.3%● unchanged vs 12-2025lowest value
02-2026: 0.3%● unchanged vs 01-2026lowest value
03-2026: 0.3%● unchanged vs 02-2026lowest value
04-2026: 0.3%● unchanged vs 03-2026lowest value
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.4%▲ +0.1 percentage points vs 06-2026
08-2026: 0.4%● unchanged vs 07-2026
09-2026: 0.4%● unchanged vs 08-2026
10-2026: 0.6%▲ +0.2 percentage points vs 09-2026
Credit of up to €12,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.58, compared with 2.29 in 2023, above the usual 1.5; short-term debt: 60.9% and cash: 1.3% of total assets), but 62.6% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 46% on solvency, 19% on liquidity and 86% on profitability.
The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 29-09-2025, 32 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
32 days early
2023
31 days early
2022
40 days early
2020
17 days late
2019
10 days early
2018
2 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 16 days before the deadline; the sector median (NACE 46) for financial year 2023 is 2 days before the deadline, and 40% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 31-03-2026 is due by 31-10-2026. Nothing is late today. The company usually files around 30 September (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
31-03-2026 year end24-10-2026 today31-10-2026 deadline
- Annual accounts filedfinancial year 2025 · micro…
- Highest result from 2019 to 2025net €94,284 ▲35.3%
- Equity above €150,000equity €185,377 ▲82.1%
Key points
By topic
Board & ownership
- Board
- 1 member
- PATTERSON WilliamDirector
Timeline
- Events
- 11
- Since
- 2018
- Next accounts
- by 31-10-2026
- 19-12-2023Purpose · Amendment of the articles ·…
- 30-09-2023Annual accounts filed
- 31-03-2023Equity above €100,000
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Founded
- 16-03-2017
- Year ends
- 31-03
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 28
- Annual meeting
- Second Friday of September at 18:00
- Purpose
- “Toutes prestations d’agent commercial dans le domaine médical, à savoir notamment le…” (deed in French)
Key facts about W.P. MED
- What is the company number of W.P. MED?
- 0672.770.719. In Belgium the VAT number is the company number with BE in front: BE 0672.770.719.
- Where is W.P. MED based?
- The registered office is at Faweux 90, 4920 Aywaille.Company details
- What does W.P. MED do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of W.P. MED?
- Private limited company (BV).
- When was W.P. MED founded?
- On 16-03-2017.
- Is W.P. MED still active?
- Yes, W.P. MED is an active enterprise in the KBO register.
- What is the turnover of W.P. MED?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is W.P. MED profitable?
- In financial year 2025, W.P. MED made a profit of €94,284.
- Where can I find the annual accounts of W.P. MED?
- W.P. MED filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of W.P. MED due?
- By 31-10-2026, for financial year 2026.Timeline
Companies related to W.P. MED
Comparable companies
- VALIMARAZedelgem
- THE FOXY'SLaarne
- Dentaurum BeneluxAntwerpen
- HELLMA BENELUXBeveren-Kruibeke-Zwijndrecht
- HALSTED HAMPTONAntwerpen
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.